Palo Alto, CA, United States of America

Xiao-Dang Yang

This inventor holds 2 USPTO granted patents. Top assignees: Astrazeneca Ab, Medimmune Limited. Active years: 2010-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao-Dang Yang. Retrieved from https://idiyas.com/inventor/xiao-dang-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Palo Alco, CA (US) (2010)
  • Palo Alto, CA (US) (2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Certainly! Here's the article about inventor Xiao-Dang Yang:

Title: Exploring the Innovations of Inventor Xiao-Dang Yang

Introduction:

Xiao-Dang Yang, a talented inventor based in Palo Alto, CA, has made significant contributions to the field of biotechnology with his inventive spirit and dedication to scientific progress.

Latest Patents:

Xiao-Dang Yang holds two groundbreaking patents, including "Targeted binding agents directed to PDGRF-alpha and uses thereof." This invention focuses on fully human monoclonal antibodies aimed at the antigen PDGFR-alpha, playing a crucial role in diagnostics and the treatment of diseases linked to PDGFR-alpha overexpression.

Career Highlights:

Throughout his career, Xiao-Dang Yang has made remarkable strides in the industry, showcasing his expertise and commitment to advancing medical technologies. Notably, he has worked with renowned companies such as AstraZeneca AB and MedImmune Limited, where he has left a lasting impact.

Collaborations:

In his professional journey, Xiao-Dang Yang has collaborated with esteemed colleagues like Naomi Laing and Jaspal Singh Kang, fostering a collaborative environment conducive to innovation and scientific breakthroughs.

Conclusion:

In conclusion, Xiao-Dang Yang's innovation and dedication have positioned him as a key figure in the biotechnology sector, with his patents and collaborations paving the way for transformative advancements in healthcare and beyond.

If you have any further requests or need additional information, feel free to let me know!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…